메뉴 건너뛰기




Volumn 14, Issue 3, 2013, Pages 155-161

The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; METHOTREXATE;

EID: 84878748528     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.1007/s40257-013-0017-9     Document Type: Review
Times cited : (28)

References (38)
  • 1
    • 0027200401 scopus 로고
    • Folic acid supplementation during methotrexate therapy: It makes sense
    • 8350325 1:STN:280:DyaK3szltlCrtQ%3D%3D
    • Morgan S, Alarcon GS, Krumdieck CL. Folic acid supplementation during methotrexate therapy: it makes sense. J Rheumatol. 1993;20(6):929-30.
    • (1993) J Rheumatol , vol.20 , Issue.6 , pp. 929-930
    • Morgan, S.1    Alarcon, G.S.2    Krumdieck, C.L.3
  • 2
    • 5644235310 scopus 로고    scopus 로고
    • The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis
    • 15476202 1:CAS:528:DC%2BD2cXpvFaisbo%3D 10.1002/art.20516
    • Morgan SL, Oster RA, Lee JY, et al. The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis. Arthritis Rheum. 2004;50(10):3104-11.
    • (2004) Arthritis Rheum , vol.50 , Issue.10 , pp. 3104-3111
    • Morgan, S.L.1    Oster, R.A.2    Lee, J.Y.3
  • 3
    • 0025037994 scopus 로고
    • The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis
    • 2405864 1:CAS:528:DyaK38Xot1Kisw%3D%3D 10.1002/art.1780330102
    • Morgan SL, Baggott JE, Vaughn WH, et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 1990;33(1):9-18.
    • (1990) Arthritis Rheum , vol.33 , Issue.1 , pp. 9-18
    • Morgan, S.L.1    Baggott, J.E.2    Vaughn, W.H.3
  • 4
    • 0028593942 scopus 로고
    • Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: A double-blind, placebo-controlled trial
    • 7978695 1:STN:280:DyaK2M%2FmvFerug%3D%3D 10.7326/0003-4819-121-11- 199412010-00002
    • Morgan SL, Baggott JE, Vaughn WH, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: a double-blind, placebo-controlled trial. Ann Intern Med. 1994;121(11):833-41.
    • (1994) Ann Intern Med , vol.121 , Issue.11 , pp. 833-841
    • Morgan, S.L.1    Baggott, J.E.2    Vaughn, W.H.3
  • 5
    • 0031936472 scopus 로고    scopus 로고
    • Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention
    • 9517760 1:CAS:528:DyaK1cXitVGkt7s%3D
    • Morgan SL, Baggott JE, Lee JY, et al. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. J Rheumatol. 1998;25(3):441-6.
    • (1998) J Rheumatol , vol.25 , Issue.3 , pp. 441-446
    • Morgan, S.L.1    Baggott, J.E.2    Lee, J.Y.3
  • 6
    • 84878764986 scopus 로고    scopus 로고
    • Methotrexate: Side effects and the role of folic acid supplementation in psoriasis: A study
    • 20944334 1:STN:280:DC%2BC3cfptlWisQ%3D%3D
    • Masuria BL, Mittal A, Gupta LK, et al. Methotrexate: side effects and the role of folic acid supplementation in psoriasis: a study. Indian J Dermatol Venereol Leprol. 1997;63(4):219-22.
    • (1997) Indian J Dermatol Venereol Leprol , vol.63 , Issue.4 , pp. 219-222
    • Masuria, B.L.1    Mittal, A.2    Gupta, L.K.3
  • 7
    • 0037368870 scopus 로고    scopus 로고
    • Hyperhomocysteinemia in children with juvenile idiopathic arthritis is not influenced by methotrexate treatment and folic acid supplementation: A pilot study
    • 12747286 1:STN:280:DC%2BD3s3is1WmtA%3D%3D
    • Huemer M, Fodinger M, Huemer C, et al. Hyperhomocysteinemia in children with juvenile idiopathic arthritis is not influenced by methotrexate treatment and folic acid supplementation: a pilot study. Clin Exp Rheumatol. 2003;21(2):249-55.
    • (2003) Clin Exp Rheumatol , vol.21 , Issue.2 , pp. 249-255
    • Huemer, M.1    Fodinger, M.2    Huemer, C.3
  • 8
    • 25844483861 scopus 로고    scopus 로고
    • Folate supplementation during methotrexate therapy for patients with psoriasis
    • 16198787 10.1016/j.jaad.2005.06.036
    • Strober BE, Menon K. Folate supplementation during methotrexate therapy for patients with psoriasis. J Am Acad Dermatol. 2005;53(4):652-9.
    • (2005) J Am Acad Dermatol , vol.53 , Issue.4 , pp. 652-659
    • Strober, B.E.1    Menon, K.2
  • 9
    • 68949149916 scopus 로고    scopus 로고
    • Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents
    • 19493586 1:CAS:528:DC%2BD1MXhtFOitrzE 10.1016/j.jaad.2009.03.027
    • Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009;61(3):451-85.
    • (2009) J Am Acad Dermatol , vol.61 , Issue.3 , pp. 451-485
    • Menter, A.1    Korman, N.J.2    Elmets, C.A.3
  • 10
    • 0036269584 scopus 로고    scopus 로고
    • Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis
    • 10.1093/rheumatology/41.6.658
    • van Ede AE, Laan RF, Blom HJ, et al. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology (Oxford). 2002;41(6):658-65.
    • (2002) Rheumatology (Oxford) , vol.41 , Issue.6 , pp. 658-665
    • Van Ede, A.E.1    Laan, R.F.2    Blom, H.J.3
  • 11
    • 10044236724 scopus 로고    scopus 로고
    • Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement
    • 15570637 1:CAS:528:DC%2BD2MXivFKrtg%3D%3D
    • Hornung N, Ellingsen T, Stengaard-Pedersen K, et al. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement. J Rheumatol. 2004;31(12):2374-81.
    • (2004) J Rheumatol , vol.31 , Issue.12 , pp. 2374-2381
    • Hornung, N.1    Ellingsen, T.2    Stengaard-Pedersen, K.3
  • 12
    • 40049098456 scopus 로고    scopus 로고
    • The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis
    • 18163165 1:CAS:528:DC%2BD1cXisFCmsb8%3D 10.1007/s00228-007-0442-x
    • Chladek J, Simkova M, Vaneckova J, et al. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis. Eur J Clin Pharmacol. 2008;64(4):347-55.
    • (2008) Eur J Clin Pharmacol , vol.64 , Issue.4 , pp. 347-355
    • Chladek, J.1    Simkova, M.2    Vaneckova, J.3
  • 13
    • 20344376922 scopus 로고    scopus 로고
    • Reversible optic neuropathy associated with low-dose methotrexate therapy
    • 15937433 10.1097/01.WNO.0000166061.73483.CE
    • Clare G, Colley S, Kennett R, et al. Reversible optic neuropathy associated with low-dose methotrexate therapy. J Neuroophthalmol. 2005;25(2):109-12.
    • (2005) J Neuroophthalmol , vol.25 , Issue.2 , pp. 109-112
    • Clare, G.1    Colley, S.2    Kennett, R.3
  • 14
    • 0032937688 scopus 로고    scopus 로고
    • Gastroduodenal lesions in children with juvenile rheumatoid arthritis
    • 10370653 1:STN:280:DyaK1M3pvVOqsw%3D%3D
    • Len C, Hilario MO, Kawakami E, et al. Gastroduodenal lesions in children with juvenile rheumatoid arthritis. Hepatogastroenterology. 1999;46(26):991-6.
    • (1999) Hepatogastroenterology , vol.46 , Issue.26 , pp. 991-996
    • Len, C.1    Hilario, M.O.2    Kawakami, E.3
  • 15
    • 60449119139 scopus 로고    scopus 로고
    • Effect of folic or folinic acid supplementation on methotrexate- associated safety and efficacy in inflammatory disease: A systematic review
    • 18945303 1:CAS:528:DC%2BD1MXktFCnt7w%3D 10.1111/j.1365-2133.2008.08876.x
    • Prey S, Paul C. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review. Br J Dermatol. 2009;160(3):622-8.
    • (2009) Br J Dermatol , vol.160 , Issue.3 , pp. 622-628
    • Prey, S.1    Paul, C.2
  • 16
    • 0027969268 scopus 로고
    • Folic acid supplementation with methotrexate therapy: What benefit if any?
    • 8089305 1:STN:280:DyaK2cznsFKlug%3D%3D 10.1016/S0190-9622(08)81746-X
    • Guzzo C. Folic acid supplementation with methotrexate therapy: what benefit if any? J Am Acad Dermatol. 1994;31(4):689.
    • (1994) J Am Acad Dermatol , vol.31 , Issue.4 , pp. 689
    • Guzzo, C.1
  • 17
    • 0030665027 scopus 로고    scopus 로고
    • The use of folates concomitantly with low-dose pulse methotrexate
    • 9361164 1:STN:280:DyaK1c%2FislShtQ%3D%3D 10.1016/S0889-857X(05)70369-0
    • Shiroky JB. The use of folates concomitantly with low-dose pulse methotrexate. Rheum Dis Clin North Am. 1997;23(4):969-80.
    • (1997) Rheum Dis Clin North Am , vol.23 , Issue.4 , pp. 969-980
    • Shiroky, J.B.1
  • 18
    • 34249798190 scopus 로고    scopus 로고
    • Folic acid in general medicine and dermatology
    • 17538801 1:CAS:528:DC%2BD2sXmtVyju7Y%3D 10.1080/09546630701247930
    • Gisondi P, Fantuzzi F, Malerba M, et al. Folic acid in general medicine and dermatology. J Dermatolog Treat. 2007;18(3):138-46.
    • (2007) J Dermatolog Treat , vol.18 , Issue.3 , pp. 138-146
    • Gisondi, P.1    Fantuzzi, F.2    Malerba, M.3
  • 19
    • 33745855136 scopus 로고    scopus 로고
    • Folic acid supplementation and methotrexate therapy for psoriasis
    • 16844540 10.1016/j.jaad.2006.01.072
    • Hughes R, Harries M, Chalmers RJ, et al. Folic acid supplementation and methotrexate therapy for psoriasis. J Am Acad Dermatol. 2006;55(2):366-7.
    • (2006) J Am Acad Dermatol , vol.55 , Issue.2 , pp. 366-367
    • Hughes, R.1    Harries, M.2    Chalmers, R.J.3
  • 20
    • 0242693163 scopus 로고    scopus 로고
    • Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis
    • 14677172 1:CAS:528:DC%2BD2cXhvFags7s%3D
    • Hoekstra M, van de Laar MA, Bernelot Moens HJ, et al. Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis. J Rheumatol. 2003;30(11):2325-9.
    • (2003) J Rheumatol , vol.30 , Issue.11 , pp. 2325-2329
    • Hoekstra, M.1    Van De Laar, M.A.2    Bernelot Moens, H.J.3
  • 21
    • 0037404893 scopus 로고    scopus 로고
    • Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis
    • 12695153 1:CAS:528:DC%2BD3sXjslCrur8%3D 10.1136/ard.62.5.423
    • Hoekstra M, van Ede AE, Haagsma CJ, et al. Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62(5):423-6.
    • (2003) Ann Rheum Dis , vol.62 , Issue.5 , pp. 423-426
    • Hoekstra, M.1    Van Ede, A.E.2    Haagsma, C.J.3
  • 22
    • 17744384488 scopus 로고    scopus 로고
    • Evidence-based use of methotrexate in children with rheumatic diseases: A consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria
    • 15688190 1:CAS:528:DC%2BD2MXjtFehtbc%3D 10.1007/s00296-004-0537-y
    • Niehues T, Horneff G, Michels H, et al. Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria. Rheumatol Int. 2005;25(3):169-78.
    • (2005) Rheumatol Int , vol.25 , Issue.3 , pp. 169-178
    • Niehues, T.1    Horneff, G.2    Michels, H.3
  • 23
    • 0033767906 scopus 로고    scopus 로고
    • Folic acid supplementation and methotrexate efficacy: Comment on articles by Schiff, Emery et al, and others
    • 11083294 1:STN:280:DC%2BD3M%2FktFChtQ%3D%3D 10.1002/1529-0131(200011)43: 11<2615: AID-ANR38>3.0.CO;2-A
    • Strand V, Morgan SL, Baggott JE, et al. Folic acid supplementation and methotrexate efficacy: comment on articles by Schiff, Emery et al, and others. Arthritis Rheum. 2000;43(11):2615-6.
    • (2000) Arthritis Rheum , vol.43 , Issue.11 , pp. 2615-2616
    • Strand, V.1    Morgan, S.L.2    Baggott, J.E.3
  • 24
    • 0033821808 scopus 로고    scopus 로고
    • Folic acid alters methotrexate availability in patients with rheumatoid arthritis
    • 10990220 1:CAS:528:DC%2BD3cXmvVWmsbg%3D
    • Bressolle F, Kinowski JM, Morel J, et al. Folic acid alters methotrexate availability in patients with rheumatoid arthritis. J Rheumatol. 2000;27(9):2110-4.
    • (2000) J Rheumatol , vol.27 , Issue.9 , pp. 2110-2114
    • Bressolle, F.1    Kinowski, J.M.2    Morel, J.3
  • 25
    • 0031183054 scopus 로고    scopus 로고
    • Defining primary care: Empirical analysis of the National Ambulatory Medical Care Survey
    • 9219494 1:STN:280:DyaK2szmtlWluw%3D%3D 10.1097/00005650-199707000-00001
    • Franks P, Clancy CM, Nutting PA. Defining primary care: empirical analysis of the National Ambulatory Medical Care Survey. Med Care. 1997;35(7):655-68.
    • (1997) Med Care , vol.35 , Issue.7 , pp. 655-668
    • Franks, P.1    Clancy, C.M.2    Nutting, P.A.3
  • 26
    • 33846686163 scopus 로고    scopus 로고
    • Describing primary care encounters: The Primary Care Network Survey and the National Ambulatory Medical Care Survey
    • 17261863 10.1370/afm.620
    • Binns HJ, Lanier D, Pace WD, et al. Describing primary care encounters: the Primary Care Network Survey and the National Ambulatory Medical Care Survey. Ann Fam Med. 2007;5(1):39-47.
    • (2007) Ann Fam Med , vol.5 , Issue.1 , pp. 39-47
    • Binns, H.J.1    Lanier, D.2    Pace, W.D.3
  • 27
    • 0033844453 scopus 로고    scopus 로고
    • The use of folic acid supplementation in psoriasis patients receiving methotrexate: A survey in the United Kingdom
    • 10971481 1:STN:280:DC%2BD3cvntFajtg%3D%3D 10.1046/j.1365-2230.2000.00638. x
    • Kirby B, Lyon CC, Griffiths CE, et al. The use of folic acid supplementation in psoriasis patients receiving methotrexate: a survey in the United Kingdom. Clin Exp Dermatol. 2000;25(4):265-8.
    • (2000) Clin Exp Dermatol , vol.25 , Issue.4 , pp. 265-268
    • Kirby, B.1    Lyon, C.C.2    Griffiths, C.E.3
  • 28
    • 0027475608 scopus 로고
    • Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis
    • 8445064 1:STN:280:DyaK3s7oslSmug%3D%3D 10.1016/0190-9622(93)70069-6
    • Duhra P. Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis. J Am Acad Dermatol. 1993;28(3):466-9.
    • (1993) J Am Acad Dermatol , vol.28 , Issue.3 , pp. 466-469
    • Duhra, P.1
  • 29
    • 0033783023 scopus 로고    scopus 로고
    • Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?
    • (Oxford)
    • Griffith SM, Fisher J, Clarke S, et al. Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term? Rheumatology (Oxford). 2000;39(10):1102-9.
    • (2000) Rheumatology , vol.39 , Issue.10 , pp. 1102-1109
    • Griffith, S.M.1    Fisher, J.2    Clarke, S.3
  • 30
    • 33646556133 scopus 로고    scopus 로고
    • Folic acid supplementation during treatment of psoriasis with methotrexate: A randomized, double-blind, placebo-controlled trial
    • 16704650 1:CAS:528:DC%2BD28XmvVKktbc%3D 10.1111/j.1365-2133.2006.07289.x
    • Salim A, Tan E, Ilchyshyn A, et al. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial. Br J Dermatol. 2006;154(6):1169-74.
    • (2006) Br J Dermatol , vol.154 , Issue.6 , pp. 1169-1174
    • Salim, A.1    Tan, E.2    Ilchyshyn, A.3
  • 31
    • 0014444410 scopus 로고
    • Methotrexate for psoriasis in weekly oral doses
    • 5761810 10.1001/archderm.1969.01610190092018
    • Roenigk HH Jr, Fowler-Bergfeld W, Curtis GH. Methotrexate for psoriasis in weekly oral doses. Arch Dermatol. 1969;99(1):86-93.
    • (1969) Arch Dermatol , vol.99 , Issue.1 , pp. 86-93
    • Roenigk Jr., H.H.1    Fowler-Bergfeld, W.2    Curtis, G.H.3
  • 32
    • 0014905447 scopus 로고
    • Methotrexate and the citrovorum factor in the treatment of psoriasis
    • 5312493 1:STN:280:DyaE3M%2FltlCmtw%3D%3D
    • Ive FA, De Saram CF. Methotrexate and the citrovorum factor in the treatment of psoriasis. Trans St Johns Hosp Dermatol Soc. 1970;56(1):45-7.
    • (1970) Trans St Johns Hosp Dermatol Soc , vol.56 , Issue.1 , pp. 45-47
    • Ive, F.A.1    De Saram, C.F.2
  • 33
    • 0027102260 scopus 로고
    • Folinic acid rescue used routinely in psoriatic patients with known methotrexate "sensitivity
    • 1362837 1:STN:280:DyaK3s7ltVOqsg%3D%3D
    • Hills RJ, Ive FA. Folinic acid rescue used routinely in psoriatic patients with known methotrexate "sensitivity". Acta Derm Venereol. 1992;72(6):438-40.
    • (1992) Acta Derm Venereol , vol.72 , Issue.6 , pp. 438-440
    • Hills, R.J.1    Ive, F.A.2
  • 34
    • 34447574771 scopus 로고    scopus 로고
    • Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis
    • 17410198 1:CAS:528:DC%2BD2sXns1ymu7g%3D 10.1038/sj.jid.5700808
    • Campalani E, Arenas M, Marinaki AM, et al. Polymorphisms in folate, pyrimidine, and purine metabolism are associated with efficacy and toxicity of methotrexate in psoriasis. J Invest Dermatol. 2007;127(8):1860-7.
    • (2007) J Invest Dermatol , vol.127 , Issue.8 , pp. 1860-1867
    • Campalani, E.1    Arenas, M.2    Marinaki, A.M.3
  • 35
    • 0029131045 scopus 로고
    • Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients
    • 7586777 1:STN:280:DyaK28%2Fhs1GitA%3D%3D
    • Leeb BF, Witzmann G, Ogris E, et al. Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients. Clin Exp Rheumatol. 1995;13(4):459-63.
    • (1995) Clin Exp Rheumatol , vol.13 , Issue.4 , pp. 459-463
    • Leeb, B.F.1    Witzmann, G.2    Ogris, E.3
  • 36
    • 0035318124 scopus 로고    scopus 로고
    • Current methods of the US Preventive Services Task Force: A review of the process
    • 11306229 1:STN:280:DC%2BD38%2FgvVWquw%3D%3D 10.1016/S0749-3797(01)00261-6
    • Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3 Suppl.):21-35.
    • (2001) Am J Prev Med , vol.20 , Issue.3 SUPPL. , pp. 21-35
    • Harris, R.P.1    Helfand, M.2    Woolf, S.H.3
  • 37
    • 0031985832 scopus 로고    scopus 로고
    • The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis: A metaanalysis of randomized controlled trials
    • 9458200 1:CAS:528:DyaK1cXlvVWnsw%3D%3D
    • Ortiz Z, Shea B, Suarez-Almazor ME, et al. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis: a metaanalysis of randomized controlled trials. J Rheumatol. 1998;25(1):36-43.
    • (1998) J Rheumatol , vol.25 , Issue.1 , pp. 36-43
    • Ortiz, Z.1    Shea, B.2    Suarez-Almazor, M.E.3
  • 38
    • 76649094231 scopus 로고    scopus 로고
    • Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: A systematic review of the literature
    • 20149325 1:STN:280:DC%2BC3c7gtlSitQ%3D%3D
    • Visser K, van der Heijde DM. Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clin Exp Rheumatol. 2009;27(6):1017-25.
    • (2009) Clin Exp Rheumatol , vol.27 , Issue.6 , pp. 1017-1025
    • Visser, K.1    Van Der Heijde, D.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.